Elsevier

The Lancet

Volume 347, Issue 9011, 11 May 1996, Pages 1290-1293
The Lancet

Articles
Severe oligozoospermia resulting from deletions of azoospermia factor gene on Y chromosome

https://doi.org/10.1016/S0140-6736(96)90938-1Get rights and content

Abstract

Summary

Background About 13% of cases of non-obstructive azoospermia are caused by deletion of the azoospermia factor (AZF), a gene or gene complex normally located on the long arm of the Y chromosome. Oligozoospermia is far more common than azoospermia, but little is known about genetic causes. We investigated whether severe oligozoospermia is caused by AZFdeletions and, if so, whether those deletions are present in mature spermatozoa.

Methods By PCR, we tested leucocyte DNA, from 35 men who presented at infertility clinics and who had severe oligozoospermia, for the presence of 118 DNA landmarks scattered across the Y chromosome. In the two men in whom Y-chromosome deletions in leucocyte DNA were detected, we also tested leucocyte DNA from the individuals' fathers, and in one man we tested sperm DNA.

Findings In two men with ejaculate sperm counts of 40 000-100 000 per mL, we detected Y-chromosome deletions in leucocyte DNA similar in location to those previously reported in azoospermic individuals. No Y-chromosome deletions were detected in the fathers of the two men. For one of the two men, sperm DNA was tested, and it showed the same Y-chromosome deletion seen in leucocytes.

Interpretation The Y-chromosome deletions in these two men are de-novo mutations, and are therefore the cause of their severe oligozoospermia. Not only is the absence of AZFcompatible with spermatogenesis, albeit at reduced rate, but also the resultant sperm bear the mutant Y chromosome. Because intracytoplasmic sperm injection is increasingly used as a means of circumventing oligozoospermia, AZFdeletions could be transmitted by this practice, and would probably result in infertile sons. In cases of severe oligozoospermia, it may be appropriate to offer Y-DNA testing and genetic counselling before starting assisted reproductive procedures.

References (19)

  • Dc Page et al.

    The sex-determining region of the human Y chromosome encodes a finger protein

    Cell

    (1987)
  • U. Gyllensten

    Haplotype analysis from single sperm or diploid cells

  • Mgr Hull et al.

    Population study of causes, treatment, and outcome of infertility

    BMJ

    (1985)
  • Ja van Zyl et al.

    Oligozoospermia: a seven-year survey of the incidence, chromosomal aberrations, treatment and pregnancy rate

    Int J Fertil

    (1975)
  • L. Tiepolo et al.

    Localization of factors controlling spermatogenesis in the non-fluorescent portion of the human Y chromosome long arm

    Hum Genet

    (1976)
  • R. Reijo et al.

    Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene

    Nature Genet

    (1995)
  • Y. Nakahori et al.

    A locus of the candidate gene family for azoospermia factor (YRRM2) is polymorphic with a null allele in Japanese males

    Hum Molec Genet

    (1994)
  • Ac Chandley et al.

    Human male infertility-Y-linked genes and spermatogenesis

    Hum Molec Genet

    (1994)
  • K. Kobayashi et al.

    PCR analysis of the Y chromosome long arm in azoospermic patients: evidence for a second locus required for spermatogenesis

    Hum Mol Genet

    (1994)
There are more references available in the full text version of this article.

Cited by (519)

  • Human-specific epigenomic states in spermatogenesis

    2024, Computational and Structural Biotechnology Journal
  • Metabolomics of male infertility

    2024, Clinica Chimica Acta
  • Clinical implications of Y chromosome microdeletions among infertile men

    2020, Best Practice and Research: Clinical Endocrinology and Metabolism
  • Round Spermatid Injection

    2020, Urologic Clinics of North America
  • Nonneoplastic Diseases of the Testis

    2020, Urologic Surgical Pathology
View all citing articles on Scopus
View full text